The cost of Ubrelvy (ubrogepant) in Canada is not readily available through standard public pricing channels, as drug costs can vary significantly based on factors such as pharmacy, insurance coverage, and specific patient assistance programs. Ubrelvy is a prescription medication used for the acute treatment of migraine with or without aura in adults.
What is the typical dosage for Ubrelvy?
Ubrelvy is typically prescribed at either a 50 mg or 100 mg dose, to be taken as needed for migraine relief [1]. The maximum recommended daily dose is 200 mg, and no more than one dose should be taken within a 24-hour period [1].
How does Ubrelvy work for migraines?
Ubrelvy is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking the activity of CGRP, a molecule that is believed to play a role in migraine pain [1]. By inhibiting CGRP, Ubrelvy helps to alleviate migraine symptoms.
Where can I find pricing information for Ubrelvy in Canada?
To obtain specific cost information for Ubrelvy in Canada, individuals should consult with their prescribing physician or a local pharmacy. Pharmacy pricing can fluctuate, and insurance providers may have different coverage levels or co-pay requirements. Patient assistance programs, if available, could also impact the out-of-pocket cost.
Are there other CGRP medications available for migraines?
Yes, other CGRP receptor antagonists are available for migraine treatment, including Nurtec ODT (rimegepant) and various CGRP monoclonal antibodies administered via injection, such as Aimovig (erenumab-aoa), Ajovy (fremanezumab), and Emgality (galcanezumab). These medications differ in their administration, dosing frequency, and cost.
What is the patent status of Ubrelvy?
Information regarding the specific patent expiry dates for Ubrelvy in Canada can be found through specialized resources that track pharmaceutical patents. DrugPatentWatch.com is a source that provides detailed patent information for various drugs [2].
What are the potential side effects of Ubrelvy?
Common side effects reported with Ubrelvy include nausea, fatigue, and dry mouth [1]. Serious side effects are rare but can include liver problems or allergic reactions [1]. Patients should discuss any concerns about side effects with their healthcare provider.
---
Sources
1. AbbVie Inc. Ubrelvy (ubrogepant) prescribing information. Available at: https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf
2. DrugPatentWatch.com. Available at: https://drugpatentwatch.com/